Membership

Robert Bosch AB

1904 was the year when Robert Bosch and Fritz Egnell signed an agreement for the sale of Bosch products and thereby laid the foundation for Bosch’s presence in Sweden.

Today Bosch in Sweden employs some 2,200 associates within the four business sectors Mobility, Industrial Technology, Consumer Goods and Energy and Building Technology.

The headquarters of Robert Bosch AB are located in Kista, north of Stockholm. Here, the divisions Mobility Aftermarket, Power Tools and Security Systems conduct sales and training. The sales office in Gothenburg is responsible for sales and development of systems and components for the automotive industry and in Lund you find our software development center.

The Bosch group also comprises the local companies Bosch Thermoteknik AB, Bosch Rexroth AB and BSH Home Appliances. Together we have production, sales, testing and research and development locations, from Arjeplog in the north to Lund in the south of Sweden.

The Jackson Laboratory

The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institute that has been at the forefront of translational research for over 90 years. Leveraging the strength of its research centers, JAX offers drug developers innovative preclinical platforms and services.

LBM Sweden

LBM Sweden develops specialty magnesium alloys enabled by a unique technology for the fabrication of biodegradable implants. The alloy facilitates the healing process and disappears through normal physiological mechanisms, reducing the need for further surgeries.

Project Medtech

Start-up & Developing Companies
We serve Medical Device, Diagnostic, Software as a Medical Device, Digital Health & Wearables, Drug Delivery, Health IT.

Accelerators & Incubators
Engage our multi-disciplinary team of medtech experts to execute your vision and ensure the success of your companies.

Hospital & Healthcare Systems
Engage our multi-disciplinary team of medtech experts to support your innovation pipeline and give individual opportunities the best chance to succeed.

Investor Groups & Funds
Investors seeking third-party expert input to evaluate an investment opportunity and help safeguard their capital.

Guardtech Nordic AB

Guardtech Nordic AB are industry-leading providers of a diverse range of standard and bespoke controlled environment design & build solutions, as well as a wide array of high-quality cleanroom-related products and services.
As part of UK-based contamination control specialists the Guardtech Group, Guardtech Nordic AB offerhigh-performance custom cleanroom design and construction solutions alongside controlled environment Servicing & Maintenance contracts, Decontamination packages and Commissioning/Validation programmes via the Guardtech Group’s six brands:

• Guardtech Cleanrooms – catering specifically to the modular cleanroom market.
• Cleanroom Solutions – larger turnkey construction projects that require complex documentation and in-depth, on-going consultation.
• Isopod Rapid Cleanrooms – a quicker, smaller, more flexible and cost-effective cleanroom pod system that boasts the same intellectual property as a Guardtech modular build.
• Isoblok Pre-Fabricated Cleanrooms – pre-configured ‘plug and play’ steel portal frame modules.
• Cleancube Mobile Cleanrooms – award-winning portable shipping container cleanroom facilities.
• Guardware Cleanroom Hardware – elite furniture & equipment solutions, including stainless steel and Trespa furniture, a wide range of separative devices, transfer hatches and measuring instruments.

Swiss Business Hub Nordics

The Swiss Business Hub Nordics is the local office of the Swiss trade promotion agency Switzerland Global Enterprise (S-GE).

Located in the Swiss embassy in Stockholm, we help Swiss companies export and find business partners in the Nordic countries.

We are always on the lookout for companies, particularly in the Nordic life science and medtech sectors, who are considering international expansion and investing in a second or third location abroad.

Emulsi Biotech

Emulsi Biotech AB, a Swedish biotechnology company specializing in lipid-based excipients for oral drug delivery. Our NanoLIPID™ platform utilizes self-assembling lipids to enhance the bioavailability of peptides and biologics. With a focus on natural, food-grade, and pharmaceutical-grade NanoLIPID™ formulations, we develop excipients designed to protect drugs in the gastrointestinal environment and enable controlled release.

Croda Pharma

Croda Pharma offers over eight decades of specialized expertise in pharmaceutical solutions. With a steadfast commitment to quality, precision, and sustainability, we are here to collaborate with industry leaders to advance pharmaceutical innovation.

Global Reach and Collaboration: Operating across Europe, North America, and Asia, Croda provides seamless global support to its partners. Our lipid technologies were instrumental in enabling the rapid development and rollout of mRNA-based COVID-19 vaccines, demonstrating our capacity to address critical challenges in healthcare.

Super Refined™ Excipients: Croda’s Super Refined™ excipients are engineered to deliver the highest levels of purity, reducing impurities that can impact drug stability and performance. These excipients ensure reliable and reproducible outcomes, supporting robust and effective formulations.

Innovative Adjuvant Systems: With over 80 years of experience, Croda has developed advanced adjuvant systems that amplify vaccine efficacy. These systems are tailored to meet stringent safety and performance requirements, enhancing immune responses across a range of vaccine platforms.

Specialized Lipid Technologies: Croda’s lipids are key components in the stabilization and delivery of nucleic acid therapies, including mRNA vaccines and gene editing technologies. Our lipids provide the reliability and functionality necessary to support groundbreaking treatments.

WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2024, WuXi Biologics is supporting 742 integrated client projects, including 16 in commercial manufacturing (excluding 8 COVID CMO projects and 1 non-COVID dormant CMO project).

WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean-energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.

Cambrex

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services.
With over 40 years of experience and a team of 2,000 experts servicing global clients from North America and Europe, Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs.